Amedeo Smart

Free Medical Literature Service

 

Amedeo

Vaccines
  Free Subscription

Articles published in
MMWR Morb Mortal Wkly Rep
    April 2024
  1. PANAGIOTAKOPOULOS L, Godfrey M, Moulia DL, Link-Gelles R, et al
    Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged >/=65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:377-381.
    >> Share

  2. KALLAY R, Doshi RH, Muhoza P, Choi MJ, et al
    Use of Ebola Vaccines - Worldwide, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:360-364.
    >> Share

  3. COLLINS JP, Crowe SJ, Ortega-Sanchez IR, Bahta L, et al
    Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged >/=10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:345-350.
    >> Share

  4. ZAMBRANO LD, Newhams MM, Simeone RM, Payne AB, et al
    Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:330-338.
    >> Share

  5. FRANKLIN D, Barbre K, Rowe TA, Reses HE, et al
    COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:339-344.
    >> Share

  6. LIKO J, Cieslak PR
    Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:317-320.
    >> Share

  7. DOSHI RH, Nsasiirwe S, Dahlke M, Atagbaza A, et al
    COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:307-311.
    >> Share

  8. MATHIS AD, Raines K, Masters NB, Filardo TD, et al
    Measles - United States, January 1, 2020-March 28, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:295-300.
    >> Share

  9. EL KALACH R, Jones-Jack N, Elam MA, Olorukooba A, et al
    Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics - United States, September 1, 2022-September 30, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:286-290.
    >> Share

    March 2024
  10. LINK-GELLES R, Rowley EAK, DeSilva MB, Dascomb K, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged >/=18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:271-276.
    >> Share

  11. THOMAS CM, Hartley A, Schmitz A, Reid HD, et al
    Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels - United States, May 2022-April 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:260-264.
    >> Share

  12. MOLINE HL, Tannis A, Toepfer AP, Williams JV, et al
    Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:209-214.
    >> Share

    February 2024
  13. ZHU S, Quint J, Leon TM, Sun M, et al
    Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza - California, October 2023-January 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:175-179.
    >> Share

  14. DECUIR J, Payne AB, Self WH, Rowley EAK, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged >/=18 Years - VISION and IVY Networks,
    MMWR Morb Mortal Wkly Rep. 2024;73:180-188.
    >> Share

  15. FRUTOS AM, Price AM, Harker E, Reeves EL, et al
    Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
    MMWR Morb Mortal Wkly Rep. 2024;73:168-174.
    >> Share

  16. OU AC, Zimmerman LA, Alexander JP Jr, Crowcroft NS, et al
    Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:162-167.
    >> Share

  17. MUSA N, Ghoniem A, Hsu CH, Mubarak S, et al
    Progress Toward Measles Elimination - World Health Organization Eastern Mediterranean Region, 2019-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:139-144.
    >> Share

  18. LINK-GELLES R, Ciesla AA, Mak J, Miller JD, et al
    Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Pro
    MMWR Morb Mortal Wkly Rep. 2024;73:77-83.
    >> Share

    January 2024
  19. MONACH PA, Anand ST, Fillmore NR, La J, et al
    Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 - Veterans Health Administration, March-September 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:57-61.
    >> Share

  20. PAYNE AB, Novosad S, Wiegand RE, Najdowski M, et al
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged >/=65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:16-23.
    >> Share

    December 2023
  21. BLACK CL, Kriss JL, Razzaghi H, Patel SA, et al
    Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1377-1382.
    >> Share

  22. RESES HE, Dubendris H, Haas L, Barbre K, et al
    Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, December 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1371-1376.
    >> Share

  23. KIDD S, Clark T, Routh J, Cineas S, et al
    Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1327-1330.
    >> Share

  24. BLAU EF, Balakrishnan MR, Skold H, Santhana Gopala Krishnan RS, et al
    Progress in Immunization Safety Monitoring - Worldwide, 2020-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1321-1326.
    >> Share


  25. QuickStats: Age-Adjusted Percentage* of Adults Aged >/=18 Years Who Received an Influenza Vaccination During the Past 12 Months,(dagger) by Sex and Race and Ethnicity( section sign) - National Health Interview Survey, United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1313.
    >> Share

  26. TANNIS A, Englund JA, Perez A, Harker EJ, et al
    SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months-4 Years - New Vaccine Surveillance Network, United States, July 2022-September 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1300-1306.
    >> Share

    November 2023
  27. BIYA O, Manu JI, Forbi JC, Wa Nganda G, et al
    Notes from the Field: House-to-House Campaign Administration of Inactivated Poliovirus Vaccine - Sokoto State, Nigeria, November 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1290-1291.
    >> Share

  28. MINTA AA, Ferrari M, Antoni S, Portnoy A, et al
    Progress Toward Measles Elimination - Worldwide, 2000-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1262-1268.
    >> Share

  29. CALLAWAY J, Durbin K, Zachary H, Barnes MM, et al
    Notes from the Field: A Cluster of Multi-Strain Invasive Pneumococcal Disease Among Persons Experiencing Homelessness and Use of Pneumococcal Conjugate Vaccine - El Paso County, Colorado, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1277-1278.
    >> Share

  30. SEITHER R, Yusuf OB, Dramann D, Calhoun K, et al
    Coverage with Selected Vaccines and Exemption from School Vaccine Requirements Among Children in Kindergarten - United States, 2022-23 School Year.
    MMWR Morb Mortal Wkly Rep. 2023;72:1217-1224.
    >> Share

  31. BELL J, Meng L, Barbre K, Haanschoten E, et al
    Influenza and Up-to-Date COVID-19 Vaccination Coverage Among Health Care Personnel - National Healthcare Safety Network, United States, 2022-23 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2023;72:1237-1243.
    >> Share

  32. LYMON H, Meng L, Reses HE, Barbre K, et al
    Declines in Influenza Vaccination Coverage Among Health Care Personnel in Acute Care Hospitals During the COVID-19 Pandemic - United States, 2017-2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1244-1247.
    >> Share

  33. HILL HA, Yankey D, Elam-Evans LD, Chen M, et al
    Vaccination Coverage by Age 24 Months Among Children Born in 2019 and 2020 - National Immunization Survey-Child, United States, 2020-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1190-1196.
    >> Share

    October 2023
  34. KAUR G, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, et al
    Routine Vaccination Coverage - Worldwide, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1155-1161.
    >> Share

  35. REGAN JJ, Moulia DL, Link-Gelles R, Godfrey M, et al
    Use of Updated COVID-19 Vaccines 2023-2024 Formula for Persons Aged >/=6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1140-1146.
    >> Share

  36. CHACKO S, Kamal M, Hastuti EB, Mildya F, et al
    Progress Toward Measles and Rubella Elimination - Indonesia, 2013-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1134-1139.
    >> Share

  37. FLEMING-DUTRA KE, Jones JM, Roper LE, Prill MM, et al
    Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - Unite
    MMWR Morb Mortal Wkly Rep. 2023;72:1115-1122.
    >> Share

  38. WHITE EB, O'Halloran A, Sundaresan D, Gilmer M, et al
    High Influenza Incidence and Disease Severity Among Children and Adolescents Aged <18 Years - United States, 2022-23 Season.
    MMWR Morb Mortal Wkly Rep. 2023;72:1108-1114.
    >> Share

  39. HAANSCHOTEN E, Dubendris H, Reses HE, Barbre K, et al
    Disparities in COVID-19 Vaccination Status Among Long-Term Care Facility Residents - United States, October 31, 2022-May 7, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1095-1098.
    >> Share

    September 2023
  40. RAZZAGHI H, Kahn KE, Calhoun K, Garacci E, et al
    Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women - United States, April 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1065-1071.
    >> Share

  41. SHEPHARD HM, Manning SE, Nestoridi E, Darling AM, et al
    Inequities in COVID-19 Vaccination Coverage Among Pregnant Persons, by Disaggregated Race and Ethnicity - Massachusetts, May 2021-October 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1052-1056.
    >> Share


  42. ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1072.
    >> Share

  43. MEGHANI M, Salvesen Von Essen B, Zapata LB, Polen K, et al
    COVID-19 Vaccination Recommendations and Practices for Women of Reproductive Age by Health Care Providers - Fall DocStyles Survey, United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:1045-1051.
    >> Share

  44. SIMEONE RM, Zambrano LD, Halasa NB, Fleming-Dutra KE, et al
    Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1057-1064.
    >> Share

  45. DAVLANTES E, Jorba J, Henderson E, Bullard K, et al
    Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use - Six African Countries, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1041-1042.
    >> Share

  46. FOWLKES AL, Nogareda F, Regan A, Loayza S, et al
    Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations - REVELAC-i Network, March-July 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:1010-1015.
    >> Share

  47. KAHN R, Zielinski L, Gedlinske A, Askelson NM, et al
    Health Care Provider Knowledge and Attitudes Regarding Adult Pneumococcal Conjugate Vaccine Recommendations - United States, September 28-October 10, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:979-984.
    >> Share

  48. SCHILDHAUER S, Saadeh K, Vance J, Quint J, et al
    Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine - California, May 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:992-996.
    >> Share

  49. MASRESHA BG, Hatcher C, Lebo E, Tanifum P, et al
    Progress Toward Measles Elimination - African Region, 2017-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:985-991.
    >> Share

    August 2023
  50. PINGALI C, Yankey D, Elam-Evans LD, Markowitz LE, et al
    Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:912-919.
    >> Share

  51. LINK-GELLES R, Ciesla AA, Rowley EAK, Klein NP, et al
    Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:886-892.
    >> Share

  52. NAVARRETE J, Barone G, Qureshi I, Woods A, et al
    SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves - United States, June 30, 2021-September 27, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:871-876.
    >> Share

  53. ROMANSON B, Moro PL, Su JR, Marquez P, et al
    Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged >/=12 Years - United States, July 13, 2022-March 13, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:850-851.
    >> Share

  54. TILLER EC, Masters NB, Raines KL, Mathis AD, et al
    Notes from the Field: Measles Outbreak - Central Ohio, 2022-2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:847-849.
    >> Share

    July 2023

  55. QuickStats: Percentage* of Adults Aged >/=18 Years who Received an Influenza Vaccination in the Past 12 Months,(dagger) by Race and Ethnicity( section sign) and Family Income( paragraph sign) - National Health Interview Survey, United States, 2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:836.
    >> Share

  56. SALIH T, Vance J, Quint J, Meza B, et al
    Demographic Disparities in Mpox Vaccination Series Completion, by Route of Vaccine Administration - California, August 9, 2022-March 31, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:827-832.
    >> Share

  57. MELGAR M, Britton A, Roper LE, Talbot HK, et al
    Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:793-801.
    >> Share

  58. KABORE HJ, Li X, Alleman MM, Manzengo CM, et al
    Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - World Health Organization African Region, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:782-787.
    >> Share

  59. KAUR G, Casey RM, Patel JC, Bloem P, et al
    Status of New Vaccine Introduction - Worldwide, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:746-750.
    >> Share

    June 2023
  60. MASTERSON JM, Luu M, Dallas KB, Daskivich LP, et al
    Disparities in COVID-19 Disease Incidence by Income and Vaccination Coverage - 81 Communities, Los Angeles, California, July 2020-September 2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:728-731.
    >> Share

  61. FAHERTY EAG, Holly T, Ogale YP, Crisler G, et al
    Notes from the Field: Emergence of an Mpox Cluster Primarily Affecting Persons Previously Vaccinated Against Mpox - Chicago, Illinois, March 18-June 12, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:696-698.
    >> Share

  62. WONG E, Barbre K, Wiegand RE, Reses HE, et al
    Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents - United States, November 20, 2022-January 8, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:690-693.
    >> Share

  63. MA KC, Dorabawila V, Leon TM, Henry H, et al
    Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged >/=18 Years - 18 U.S. Jurisdictions, September 2021-December 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:683-689.
    >> Share

  64. KHANAL S, Bahl S, Sangal L, Dhongde D, et al
    Progress Toward Rubella Elimination - World Health Organization South-East Asia Region, 2013-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:678-682.
    >> Share

  65. MOULIA DL, Wallace M, Roper LE, Godfrey M, et al
    Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged >/=6 Months - United States, April 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:657-662.
    >> Share

  66. JOHNSON AG, Linde L, Payne AB, Ali AR, et al
    Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged >/=65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months - 20 U.S. Jurisdictions, September 18, 2022-April 1, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:667-669.
    >> Share

  67. HAUSE AM, Marquez P, Zhang B, Moro PL, et al
    Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:621-626.
    >> Share

  68. KOTA KK, Chesson H, Hong J, Zelaya C, et al
    Progress Toward Equitable Mpox Vaccination Coverage: A Shortfall Analysis - United States, May 2022-April 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:627-632.
    >> Share

  69. STEHLING-ARIZA T, Wilkinson AL, Diop OM, Jorba J, et al
    Surveillance To Track Progress Toward Poliomyelitis Eradication - Worldwide, 2021-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:613-620.
    >> Share

  70. JONES JM, Manrique IM, Stone MS, Grebe E, et al
    Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:601-605.
    >> Share

    May 2023
  71. LINK-GELLES R, Weber ZA, Reese SE, Payne AB, et al
    Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:579-588.
    >> Share

  72. DALTON AF, Diallo AO, Chard AN, Moulia DL, et al
    Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:553-558.
    >> Share

  73. ROSENBERG ES, Dorabawila V, Hart-Malloy R, Anderson BJ, et al
    Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:559-563.
    >> Share

  74. LEE SE, Greene SA, Burns CC, Tallis G, et al
    Progress Toward Poliomyelitis Eradication - Worldwide, January 2021-March 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:517-522.
    >> Share

  75. SILK BJ, Scobie HM, Duck WM, Palmer T, et al
    COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration - United States, May 11, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:523-528.
    >> Share

    April 2023
  76. DECUIR J, Surie D, Zhu Y, Gaglani M, et al
    Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31
    MMWR Morb Mortal Wkly Rep. 2023;72:463-468.
    >> Share

  77. ELAM-EVANS LD, Jones CP, Vashist K, Yankey D, et al
    The Association of Reported Experiences of Racial and Ethnic Discrimination in Health Care with COVID-19 Vaccination Status and Intent - United States, April 22, 2021-November 26, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:437-444.
    >> Share

  78. KOTA KK, Hong J, Zelaya C, Riser AP, et al
    Racial and Ethnic Disparities in Mpox Cases and Vaccination Among Adult Males - United States, May-December 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:398-403.
    >> Share

  79. DAVLANTES E, Greene SA, Tobolowsky FA, Biya O, et al
    Update on Wild Poliovirus Type 1 Outbreak - Southeastern Africa, 2021-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:391-397.
    >> Share

  80. OLIVER SE, Rubis AB, Soeters HM, Reingold A, et al
    Secondary Cases of Invasive Disease Caused by Encapsulated and Nontypeable Haemophilus influenzae - 10 U.S. Jurisdictions, 2011-2018.
    MMWR Morb Mortal Wkly Rep. 2023;72:386-390.
    >> Share

  81. BIGOUETTE JP, Henderson E, Traore MA, Wassilak SGF, et al
    Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2021-December 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:366-371.
    >> Share

    March 2023
  82. OWENS LE, Currie DW, Kramarow EA, Siddique S, et al
    JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:342-347.
    >> Share

  83. FAIRLIE T, Chu B, Thomas ES, Querns AK, et al
    School-Based Interventions to Increase Student COVID-19 Vaccination Coverage in Public School Populations with Low Coverage - Seattle, Washington, December 2021-June 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:283-287.
    >> Share


  84. Correction and Republication: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, Sept
    MMWR Morb Mortal Wkly Rep. 2023;72:292.
    >> Share

  85. TENFORDE MW, Weber ZA, Natarajan K, Klein NP, et al
    Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
    MMWR Morb Mortal Wkly Rep. 2023;71:1637-1646.
    >> Share

  86. WADDELL CJ, Filardo TD, Prasad N, Pellegrini GJ Jr, et al
    Possible Undetected Mpox Infection Among Persons Accessing Homeless Services and Staying in Encampments - San Francisco, California, October-November 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:227-231.
    >> Share

    February 2023
  87. MCLEAN HQ, Petrie JG, Hanson KE, Meece JK, et al
    Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness - Wisconsin, October 2022-February 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:201-205.
    >> Share

  88. LU PJ, Zhou T, Santibanez TA, Jain A, et al
    COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults - United States, November-December 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:190-198.
    >> Share

  89. MURTHY BP, Fast HE, Zell E, Murthy N, et al
    COVID-19 Vaccination Coverage and Demographic Characteristics of Infants and Children Aged 6 Months-4 Years - United States, June 20-December 31, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:183-189.
    >> Share

  90. HANCUH M, Walldorf J, Minta AA, Tevi-Benissan C, et al
    Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction - Worldwide, 2018-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:171-176.
    >> Share

  91. FLEMING-DUTRA KE, Ciesla AA, Roper LE, Smith ZR, et al
    Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:177-182.
    >> Share

  92. JOHNSON AG, Linde L, Ali AR, DeSantis A, et al
    COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged >/=12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination - 24 U.S. Jurisdictions, October 3, 2021-December 24, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:145-152.
    >> Share

  93. LINK-GELLES R, Ciesla AA, Roper LE, Scobie HM, et al
    Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing
    MMWR Morb Mortal Wkly Rep. 2023;72:119-124.
    >> Share

  94. WONG MK, Brooks DJ, Ikejezie J, Gacic-Dobo M, et al
    COVID-19 Mortality and Progress Toward Vaccinating Older Adults - World Health Organization, Worldwide, 2020-2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:113-118.
    >> Share

  95. PATEL P, Twentyman E, Koumans E, Rosenblum H, et al
    Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages - United States, January 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:128-131.
    >> Share

    January 2023
  96. DUBENDRIS H, Reses HE, Wong E, Dollard P, et al
    Laboratory-Confirmed COVID-19 Case Incidence Rates Among Residents in Nursing Homes by Up-to-Date Vaccination Status - United States, October 10, 2022-January 8, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:95-99.
    >> Share

  97. CANADAY DH, Oyebanji OA, White EM, Bosch J, et al
    SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:100-106.
    >> Share

  98. SINCLAIR AH, Taylor MK, Weitz JS, Beckett SJ, et al
    Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults - United States, November 1-December 10, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:73-75.
    >> Share

  99. THOMAS CM, White EB, Kojima N, Fill MA, et al
    Early and Increased Influenza Activity Among Children - Tennessee, 2022-23 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2023;72:49-54.
    >> Share

  100. HAUSE AM, Marquez P, Zhang B, Su JR, et al
    Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:39-43.
    >> Share

  101. HILL HA, Chen M, Elam-Evans LD, Yankey D, et al
    Vaccination Coverage by Age 24 Months Among Children Born During 2018-2019 - National Immunization Survey-Child, United States, 2019-2021.
    MMWR Morb Mortal Wkly Rep. 2023;72:33-38.
    >> Share

  102. SEITHER R, Calhoun K, Yusuf OB, Dramann D, et al
    Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2021-22 School Year.
    MMWR Morb Mortal Wkly Rep. 2023;72:26-32.
    >> Share

  103. VALIER MR, Elam-Evans LD, Mu Y, Santibanez TA, et al
    Racial and Ethnic Differences in COVID-19 Vaccination Coverage Among Children and Adolescents Aged 5-17 Years and Parental Intent to Vaccinate Their Children - National Immunization Survey-Child COVID Module, United States, December 2020-September 202
    MMWR Morb Mortal Wkly Rep. 2023;72:1-8.
    >> Share

    December 2022
  104. TENFORDE MW, Weber ZA, Natarajan K, Klein NP, et al
    Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1616-1624.
    >> Share

  105. SURIE D, DeCuir J, Zhu Y, Gaglani M, et al
    Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged >/=65 Years - IVY Network, 18 States, September 8-November 30, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1625-1630.
    >> Share

  106. FARRAR JL, Lewis NM, Houck K, Canning M, et al
    Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1610-1615.
    >> Share

  107. MURUGAN R, VanderEnde K, Dhawan V, Haldar P, et al
    Progress Toward Measles and Rubella Elimination - India, 2005-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:1569-1575.
    >> Share

  108. PAYNE AB, Ray LC, Cole MM, Canning M, et al
    Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1560-1564.
    >> Share

  109. DUFFY J, Marquez P, Moro P, Weintraub E, et al
    Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak - United States, May 22-October 21, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1555-1559.
    >> Share

  110. LINK-GELLES R, Ciesla AA, Fleming-Dutra KE, Smith ZR, et al
    Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1526-1530.
    >> Share

  111. AKINBAMI LJ, Kruszon-Moran D, Wang CY, Storandt RJ, et al
    SARS-CoV-2 Serology and Self-Reported Infection Among Adults - National Health and Nutrition Examination Survey, United States, August 2021-May 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1522-1525.
    >> Share

  112. SHAH MM, Joyce B, Plumb ID, Sahakian S, et al
    Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 - United States, April-September 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1531-1537.
    >> Share

    November 2022
  113. MINTA AA, Ferrari M, Antoni S, Portnoy A, et al
    Progress Toward Regional Measles Elimination - Worldwide, 2000-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:1489-1495.
    >> Share

  114. KROW-LUCAL E, Marin M, Shepersky L, Bahta L, et al
    Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1465-1470.
    >> Share

  115. SANTIBANEZ TA, Zhou T, Black CL, Vogt TM, et al
    Sociodemographic Variation in Early Uptake of COVID-19 Vaccine and Parental Intent and Attitudes Toward Vaccination of Children Aged 6 Months-4 Years - United States, July 1-29, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1479-1484.
    >> Share

  116. ROSENBLUM HG, Wallace M, Godfrey M, Roper LE, et al
    Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1436-1441.
    >> Share

  117. HAMID S, Woodworth K, Pham H, Milucky J, et al
    COVID-19-Associated Hospitalizations Among U.S. Infants Aged <6 Months - COVID-NET, 13 States, June 2021-August 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1442-1448.
    >> Share

  118. HAUSE AM, Marquez P, Zhang B, Myers TR, et al
    Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged >/=12 Years - United States, August 31-October 23, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1401-1406.
    >> Share

  119. RACHLIN A, Danovaro-Holliday MC, Murphy P, Sodha SV, et al
    Routine Vaccination Coverage - Worldwide, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:1396-1400.
    >> Share

  120. RYERSON AB, Lang D, Alazawi MA, Neyra M, et al
    Wastewater Testing and Detection of Poliovirus Type 2 Genetically Linked to Virus Isolated from a Paralytic Polio Case - New York, March 9-October 11, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1418-1424.
    >> Share

    October 2022
  121. BLACK CL, O'Halloran A, Hung MC, Srivastav A, et al
    Vital Signs: Influenza Hospitalizations and Vaccination Coverage by Race and Ethnicity-United States, 2009-10 Through 2021-22 Influenza Seasons.
    MMWR Morb Mortal Wkly Rep. 2022;71:1366-1373.
    >> Share

  122. SOELAEMAN RH, Mendoza L, McDonald R, Hand J, et al
    Characteristics of JYNNEOS Vaccine Recipients Before and During a Large Multiday LGBTQIA+ Festival - Louisiana, August 9-September 5, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1379-1381.
    >> Share

  123. MILLMAN AJ, Denson DJ, Allen ML, Malone JA, et al
    A Health Equity Approach for Implementation of JYNNEOS Vaccination at Large, Community-Based LGBTQIA+ Events - Georgia, August 27-September 5, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1382-1883.
    >> Share

  124. KRISS JL, Boersma PM, Martin E, Reed K, et al
    Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox - United States, May 22-October 10, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1374-1378.
    >> Share

  125. OLIVARES BARRAZA MF, Fasce RA, Nogareda F, Marcenac P, et al
    Influenza Incidence and Vaccine Effectiveness During the Southern Hemisphere Influenza Season - Chile, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1353-1358.
    >> Share

  126. BOEHMER TK, Koumans EH, Skillen EL, Kappelman MD, et al
    Racial and Ethnic Disparities in Outpatient Treatment of COVID-19 - United States, January-July 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1359-1365.
    >> Share

  127. BRITTON A, Embi PJ, Levy ME, Gaglani M, et al
    Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1335-1342.
    >> Share

  128. RAZZAGHI H, Srivastav A, de Perio MA, Laney AS, et al
    Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel - United States, 2021-22.
    MMWR Morb Mortal Wkly Rep. 2022;71:1319-1326.
    >> Share

  129. SURIE D, Bonnell L, Adams K, Gaglani M, et al
    Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December
    MMWR Morb Mortal Wkly Rep. 2022;71:1327-1334.
    >> Share

  130. MBAEYI C, Baig S, Safdar MR, Khan Z, et al
    Progress Toward Poliomyelitis Eradication - Pakistan, January 2021-July 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1313-1318.
    >> Share

  131. PAYNE AB, Ray LC, Kugeler KJ, Fothergill A, et al
    Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving >/=1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1278-1282.
    >> Share


  132. QuickStats: Percentage* of Residential Care Communities(dagger) that Offer Annual Influenza Vaccination to Residents and to Employees and Contract Staff Members, by Community Bed Size - United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:1291.
    >> Share

  133. PEREZ A, Lively JY, Curns A, Weinberg GA, et al
    Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:1253-1259.
    >> Share

    September 2022
  134. MCCONEGHY KW, White EM, Blackman C, Santostefano CM, et al
    Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents - 19 States, March 29-July 25, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1235-1238.
    >> Share

  135. FOSTER MA, Hofmeister MG, Yin S, Montgomery MP, et al
    Widespread Hepatitis A Outbreaks Associated with Person-to-Person Transmission - United States, 2016-2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:1229-1234.
    >> Share

  136. KOBAYASHI M, Farrar JL, Gierke R, Leidner AJ, et al
    Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1174-1181.
    >> Share

  137. YAO N, Liu Y, Xu JW, Wang Q, et al
    Detection of a Highly Divergent Type 3 Vaccine-Derived Poliovirus in a Child with a Severe Primary Immunodeficiency Disorder - Chongqing, China, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1148-1150.
    >> Share

  138. FAST HE, Murthy BP, Zell E, Meng L, et al
    Booster COVID-19 Vaccinations Among Persons Aged >/=5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged >/=50 Years - United States, August 13, 2021-August 5, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1121-1125.
    >> Share

  139. HAUSE AM, Marquez P, Zhang B, Myers TR, et al
    COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months-5 Years - United States, June 18, 2022-August 21, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1115-1120.
    >> Share

  140. PINGALI C, Yankey D, Elam-Evans LD, Markowitz LE, et al
    National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:1101-1108.
    >> Share

  141. LUTRICK K, Fowlkes A, Rivers P, Herder K, et al
    Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years - PROTECT Cohort, Four States, July 2021-May 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1109-1114.
    >> Share

    August 2022
  142. HAVERS FP, Patel K, Whitaker M, Milucky J, et al
    Laboratory-Confirmed COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance - COVID-19-Associated Hospitalization Surveillance Network, 14 States, June 20, 2021-May 31, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1085-1091.
    >> Share

  143. LATZER M, Pieracci EG, Altenburger A, Stauffer KE, et al
    Review of CDC's Suspension of and Advance Written Approval Process for Dogs Entering the United States from Egypt - May 2019-December 2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:1081-1084.
    >> Share

  144. HAUSE AM, Baggs J, Marquez P, Myers TR, et al
    Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1047-1051.
    >> Share

  145. KHANAL S, Kassem AM, Bahl S, Jayantha L, et al
    Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:1042-1046.
    >> Share

  146. LINK-GELLES R, Lutterloh E, Schnabel Ruppert P, Backenson PB, et al
    Public Health Response to a Case of Paralytic Poliomyelitis in an Unvaccinated Person and Detection of Poliovirus in Wastewater - New York, June-August 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1065-1068.
    >> Share

  147. TWENTYMAN E, Wallace M, Roper LE, Anderson TC, et al
    Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged >/=18 years - United States, July 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:988-992.
    >> Share

    July 2022
  148. HAUSE AM, Baggs J, Marquez P, Abara WE, et al
    Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged >/=50 Years - United States, March 29, 2022-July 10, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:971-976.
    >> Share

  149. KHETSURIANI N, Lesi O, Desai S, Armstrong PA, et al
    Progress Toward the Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Worldwide, 2016-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:958-963.
    >> Share

  150. LINK-GELLES R, Levy ME, Gaglani M, Irving SA, et al
    Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:931-939.
    >> Share

  151. MERCED-MORALES A, Daly P, Abd Elal AI, Ajayi N, et al
    Influenza Activity and Composition of the 2022-23 Influenza Vaccine - United States, 2021-22 Season.
    MMWR Morb Mortal Wkly Rep. 2022;71:913-919.
    >> Share

  152. HAUSE AM, Baggs J, Marquez P, Abara WE, et al
    Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged >/=12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:899-903.
    >> Share


  153. Erratum: Vol. 71, No. 22: Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Prac
    MMWR Morb Mortal Wkly Rep. 2022;71:886.
    >> Share

  154. SINGSON JRC, Kirley PD, Pham H, Rothrock G, et al
    Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 - COVID-NET, 10 States, March 2020-February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:878-884.
    >> Share

  155. FLEMING-DUTRA KE, Wallace M, Moulia DL, Twentyman E, et al
    Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:859-868.
    >> Share

  156. DECUIR J, Meng L, Pan Y, Vogt T, et al
    COVID-19 Vaccine Provider Availability and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 1, 2021-April 25, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:847-851.
    >> Share

    June 2022
  157. MALDEN DE, Hong V, Lewin BJ, Ackerson BK, et al
    Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:830-833.
    >> Share

  158. MARTIN J, Burns CC, Jorba J, Shulman LM, et al
    Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:786-790.
    >> Share

  159. KRISS JL, Hung MC, Srivastav A, Black CL, et al
    COVID-19 Vaccination Coverage, by Race and Ethnicity - National Immunization Survey Adult COVID Module, United States, December 2020-November 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:757-763.
    >> Share

  160. DAVLANTES E
    Notes from the Field: Initial Outbreak Response Activity Following Wild Poliovirus Type 1 Detection - Malawi, February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:776-777.
    >> Share

  161. RAO AK, Petersen BW, Whitehill F, Razeq JH, et al
    Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 202
    MMWR Morb Mortal Wkly Rep. 2022;71:734-742.
    >> Share

    May 2022
  162. SAPKOTA S, Caruso E, Kobau R, Radhakrishnan L, et al
    Seizure- or Epilepsy-Related Emergency Department Visits Before and During the COVID-19 Pandemic - United States, 2019-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:703-708.
    >> Share

  163. WHITEHILL F, Bonaparte S, Hartloge C, Greenberg L, et al
    Rabies in a Dog Imported from Azerbaijan - Pennsylvania, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:686-689.
    >> Share

  164. RACHLIN A, Patel JC, Burns CC, Jorba J, et al
    Progress Toward Polio Eradication - Worldwide, January 2020-April 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:650-655.
    >> Share

  165. RAO AK, Briggs D, Moore SM, Whitehill F, et al
    Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:619-627.
    >> Share

  166. PRASAD N, Derado G, Nanduri SA, Reses HE, et al
    Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:633-637.
    >> Share

    April 2022
  167. SEITHER R, Laury J, Mugerwa-Kasujja A, Knighton CL, et al
    Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2020-21 School Year.
    MMWR Morb Mortal Wkly Rep. 2022;71:561-568.
    >> Share

  168. SHI DS, Whitaker M, Marks KJ, Anglin O, et al
    Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:574-581.
    >> Share

  169. PLUMB ID, Feldstein LR, Barkley E, Posner AB, et al
    Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection - United States, June 2021-February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:549-555.
    >> Share

  170. SMITH DJ, Hakim AJ, Leung GM, Xu W, et al
    COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:545-548.
    >> Share

  171. WILKINSON AL, Diop OM, Jorba J, Gardner T, et al
    Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2020-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:538-544.
    >> Share

  172. BLOCK JP, Boehmer TK, Forrest CB, Carton TW, et al
    Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:517-523.
    >> Share

  173. NATARAJAN K, Prasad N, Dascomb K, Irving SA, et al
    Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VIS
    MMWR Morb Mortal Wkly Rep. 2022;71:495-502.
    >> Share

  174. WENG MK, Doshani M, Khan MA, Frey S, et al
    Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:477-483.
    >> Share

    March 2022
  175. TAYLOR CA, Whitaker M, Anglin O, Milucky J, et al
    COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:466-473.
    >> Share

  176. TENFORDE MW, Self WH, Gaglani M, Ginde AA, et al
    Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:459-465.
    >> Share

  177. WALLACE M, Moulia D, Blain AE, Ricketts EK, et al
    The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged >/=18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United Sta
    MMWR Morb Mortal Wkly Rep. 2022;71:416-421.
    >> Share

  178. FOWLKES AL, Yoon SK, Lutrick K, Gwynn L, et al
    Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:422-428.
    >> Share

  179. CHUNG JR, Kim SS, Kondor RJ, Smith C, et al
    Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:365-370.
    >> Share

  180. KIM C, Yee R, Bhatkoti R, Carranza D, et al
    COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:378-383.
    >> Share

  181. O'CONNOR P, Huseynov S, Nielsen CF, Saidzoda F, et al
    Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak - Tajikistan, 2020-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:361-362.
    >> Share

  182. HAUSE AM, Baggs J, Marquez P, Abara WE, et al
    Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:347-351.
    >> Share

  183. SAELEE R, Zell E, Murthy BP, Castro-Roman P, et al
    Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-January 31, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:335-340.
    >> Share

  184. KLEIN NP, Stockwell MS, Demarco M, Gaglani M, et al
    Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Net
    MMWR Morb Mortal Wkly Rep. 2022;71:352-358.
    >> Share

    February 2022
  185. MACK CD, Wasserman EB, Killerby ME, Soelaeman RH, et al
    Results from a Test-to-Release from Isolation Strategy Among Fully Vaccinated National Football League Players and Staff Members with COVID-19 - United States, December 14-19, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:299-305.
    >> Share

  186. MALENFANT JH, Joyce A, Choi MJ, Cossaboom CM, et al
    Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations - United States, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:290-292.
    >> Share

  187. HAUSE AM, Baggs J, Marquez P, Myers TR, et al
    Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:249-254.
    >> Share

  188. FERDINANDS JM, Rao S, Dixon BE, Mitchell PK, et al
    Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States,
    MMWR Morb Mortal Wkly Rep. 2022;71:255-263.
    >> Share

  189. SERVIES TE, Larsen EC, Lindsay RC, Jones JS, et al
    Notes from the Field: Outbreak of COVID-19 Among a Highly Vaccinated Population Aboard a U.S. Navy Ship After a Port Visit - Reykjavik, Iceland, July 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:279-281.
    >> Share

  190. HALASA NB, Olson SM, Staat MA, Newhams MM, et al
    Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:264-270.
    >> Share

  191. SMITH-JEFFCOAT SE, Pomeroy MA, Sleweon S, Sami S, et al
    Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention - New York City, November 18-December 20, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:238-242.
    >> Share

  192. ZIMMERMAN LA, Knapp JK, Antoni S, Grant GB, et al
    Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2012-2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:196-201.
    >> Share

  193. DANZA P, Koo TH, Haddix M, Fisher R, et al
    SARS-CoV-2 Infection and Hospitalization Among Adults Aged >/=18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:177-181.
    >> Share

  194. MCNAGHTEN AD, Brewer NT, Hung MC, Lu PJ, et al
    COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity - United States, August 29-October 30, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:171-176.
    >> Share

  195. TESORIERO JM, Patterson W, Daskalakis D, Chicoine J, et al
    Notes from the Field: COVID-19 Vaccination Among Persons Living with Diagnosed HIV Infection - New York, October 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:182-184.
    >> Share

    January 2022
  196. KOBAYASHI M, Farrar JL, Gierke R, Britton A, et al
    Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:109-117.
    >> Share

  197. JOHNSON AG, Amin AB, Ali AR, Hoots B, et al
    COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:132-138.
    >> Share

  198. LEON TM, Dorabawila V, Nelson L, Lutterloh E, et al
    COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:125-131.
    >> Share

  199. TENFORDE MW, Patel MM, Gaglani M, Ginde AA, et al
    Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:118-124.
    >> Share

  200. OLIVER SE, Wallace M, See I, Mbaeyi S, et al
    Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:90-95.
    >> Share

  201. ANDERSON TC, Masters NB, Guo A, Shepersky L, et al
    Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged >/=19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:80-84.
    >> Share

  202. THOMPSON MG, Natarajan K, Irving SA, Rowley EA, et al
    Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2
    MMWR Morb Mortal Wkly Rep. 2022;71:139-145.
    >> Share

  203. SADIGH KS, Akbar IE, Wadood MZ, Shukla H, et al
    Progress Toward Poliomyelitis Eradication - Afghanistan, January 2020-November 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:85-89.
    >> Share

  204. ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
    Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:52-58.
    >> Share

  205. LIPKIND HS, Vazquez-Benitez G, DeSilva M, Vesco KK, et al
    Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:26-30.
    >> Share

  206. YEK C, Warner S, Wiltz JL, Sun J, et al
    Risk Factors for Severe COVID-19 Outcomes Among Persons Aged >/=18 Years Who Completed a Primary COVID-19 Vaccination Series - 465 Health Care Facilities, United States, December 2020-October 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:19-25.
    >> Share

    December 2021
  207. LUTRICK K, Rivers P, Yoo YM, Grant L, et al
    Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12-17 Years - Arizona, July-December 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1761-1765.
    >> Share


  208. QuickStats: Percentage* of Children and Adolescents Aged 1-17 Years Who Received an Influenza Vaccine Within the Past 12 Months,(dagger) by Health Insurance Coverage( section sign) and Age Group - National Health Interview Survey, United States, 2019-
    MMWR Morb Mortal Wkly Rep. 2021;70:1785.
    >> Share

  209. HAUSE AM, Baggs J, Marquez P, Myers TR, et al
    COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1755-1760.
    >> Share

  210. WANGA V, Gerdes ME, Shi DS, Choudhary R, et al
    Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1766-1772.
    >> Share

  211. FAST HE, Zell E, Murthy BP, Murthy N, et al
    Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged >/=65 Years - United States, August 13, 2021-November 19, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1735-1739.
    >> Share

  212. NGUYEN KH, Yankey D, Lu PJ, Kriss JL, et al
    Report of Health Care Provider Recommendation for COVID-19 Vaccination Among Adults, by Recipient COVID-19 Vaccination Status and Attitudes - United States, April-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1723-1730.
    >> Share

  213. BAJEMA KL, Dahl RM, Evener SL, Prill MM, et al
    Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1700-1705.
    >> Share

  214. ALLEMAN MM, Jorba J, Henderson E, Diop OM, et al
    Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2020-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1691-1699.
    >> Share

  215. MONTGOMERY MP, Meehan AA, Cooper A, Toews KA, et al
    Notes from the Field: COVID-19 Vaccination Coverage Among Persons Experiencing Homelessness - Six U.S. Jurisdictions, December 2020-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1676-1678.
    >> Share

    November 2021
  216. SHAH MM, Perez A, Lively JY, Avadhanula V, et al
    Enterovirus D68-Associated Acute Respiratory Illness horizontal line New Vaccine Surveillance Network, United States, July-November 2018-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1623-1628.
    >> Share

  217. KASEHAGEN L, Byers P, Taylor K, Kittle T, et al
    COVID-19-Associated Deaths After SARS-CoV-2 Infection During Pregnancy - Mississippi, March 1, 2020-October 6, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1646-1648.
    >> Share

  218. NALEWAY AL, Groom HC, Crawford PM, Salas SB, et al
    Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged >/=12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1608-1612.
    >> Share

  219. WOODWORTH KR, Moulia D, Collins JP, Hadler SC, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1579-1583.
    >> Share


  220. QuickStats: Percentage* of Adults Aged >/=18 Years Who Received an Influenza Vaccination in the Past 12 Months,(dagger) by Sex and Age Group - National Health Interview Survey,( section sign) United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1586.
    >> Share

  221. ROMAN PC, Kirtland K, Zell ER, Jones-Jack N, et al
    Influenza Vaccinations During the COVID-19 Pandemic - 11 U.S. Jurisdictions, September-December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1575-1578.
    >> Share

  222. DIXON MG, Ferrari M, Antoni S, Li X, et al
    Progress Toward Regional Measles Elimination - Worldwide, 2000-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1563-1569.
    >> Share

  223. EMBI PJ, Levy ME, Naleway AL, Patel P, et al
    Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1553-1559.
    >> Share

  224. BOZIO CH, Grannis SJ, Naleway AL, Ong TC, et al
    Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1539-1544.
    >> Share

  225. MBAEYI S, Oliver SE, Collins JP, Godfrey M, et al
    The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1545-1552.
    >> Share

    October 2021
  226. XU S, Huang R, Sy LS, Glenn SC, et al
    COVID-19 Vaccination and Non-COVID-19 Mortality Risk - Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1520-1524.
    >> Share

  227. MUHOZA P, Danovaro-Holliday MC, Diallo MS, Murphy P, et al
    Routine Vaccination Coverage - Worldwide, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1495-1500.
    >> Share

  228. OLSON SM, Newhams MM, Halasa NB, Price AM, et al
    Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1483-1488.
    >> Share

  229. BLAU EF, Flinchum A, Gaub KL, Hartnett KP, et al
    Mycobacterium porcinum Skin and Soft Tissue Infections After Vaccinations - Indiana, Kentucky, and Ohio, September 2018-February 2019.
    MMWR Morb Mortal Wkly Rep. 2021;70:1472-1477.
    >> Share

  230. HILL HA, Yankey D, Elam-Evans LD, Singleton JA, et al
    Vaccination Coverage by Age 24 Months Among Children Born in 2017 and 2018 - National Immunization Survey-Child, United States, 2018-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1435-1440.
    >> Share

  231. VAN NAARDEN BRAUN K, Drexler M, Rozenfeld RA, Deener-Agus E, et al
    Multicomponent Strategies to Prevent SARS-CoV-2 Transmission - Nine Overnight Youth Summer Camps, United States, June-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1420-1424.
    >> Share

  232. HAUSE AM, Baggs J, Gee J, Marquez P, et al
    Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1379-1384.
    >> Share

  233. MBAEYI C, Baig S, Khan Z, Young H, et al
    Progress Toward Poliomyelitis Eradication - Pakistan, January 2020-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1359-1364.
    >> Share

  234. RYERSON AB, Rice CE, Hung MC, Patel SA, et al
    Disparities in COVID-19 Vaccination Status, Intent, and Perceived Access for Noninstitutionalized Adults, by Disability Status - National Immunization Survey Adult COVID Module, United States, May 30-June 26, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1365-1371.
    >> Share

    September 2021
  235. HAGAN LM, McCormick DW, Lee C, Sleweon S, et al
    Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1349-1354.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016